Neurocrine Biosciences shares owned by Washington Capital Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Washington Capital Management
from 13F filings
Historical chart of Washington Capital Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Washington Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Washington Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $552k | 4.0k | 137.92 |
| 2023-12-31 | $626k | 4.8k | 131.76 |
| 2023-09-30 | $647k | 5.8k | 112.50 |
| 2023-06-30 | $542k | 5.8k | 94.30 |
| 2023-03-31 | $506k | 5.0k | 101.22 |
| 2022-12-31 | $597k | 5.0k | 119.44 |
| 2022-09-30 | $690k | 6.5k | 106.21 |
| 2022-06-30 | $634k | 6.5k | 97.48 |
| 2022-03-31 | $609k | 6.5k | 93.75 |
| 2021-12-31 | $554k | 6.5k | 85.17 |
| 2021-09-30 | $623k | 6.5k | 95.91 |
| 2021-06-30 | $633k | 6.5k | 97.38 |
| 2021-03-31 | $632k | 6.5k | 97.23 |
| 2020-12-31 | $623k | 6.5k | 95.85 |
| 2020-09-30 | $519k | 5.4k | 96.11 |
More positions owned by Washington Capital Management
View all positions for Washington Capital Management